Patent · US Active

Lipid formulation

US8158601B2 · kind B2 · utility

293Cited by

0References

30Claims

0Family size

Assignee

Alnylam Pharmaceuticals, Inc. · US

Inventors

Jianxin Chen · Cambridge, US
Steven M. Ansell · Vancouver, CA
Akin Akinc · Cambridge, US
Joseph R. Dorkin · Somerville, US
Xiaojun Qin · Cambridge, US
William Cantley · Cambridge, US
Muthiah Manoharan · Carlsbad, US
Kallanthottathil G. Rajeev · Wayland, US
Jayaprakash K. Narayanannair · Cambridge, US
Muthusamy Jayaraman · Cambridge, US

Key dates

Filing date	Jun 10, 2010
Grant date	Apr 17, 2012
Priority date	—
Expiry date	Nov 10, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention features a cationic lipid of formula I, Also disclosed are targeting lipids, and specific lipid formulations comprising such targeting lipids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.